ABPI Proposes ‘World-First’ Investment Facility As Part Of New Pricing Deal
A ‘Medicines Equity Partnership’ Is Also On The Cards
The Association of the British Pharmaceutical Industry says a new type of investment facility funded by the pharmaceutical industry could form part of a new pricing agreement for branded medicines, and would be a “genuine Brexit dividend.”
